American Oncology Network Achieves Success in First Performance Period of CMMI’s Enhancing Oncology Model
American Oncology Network (AON) has reported significant success in the first performance period of the Centers for Medicare & Medicaid Innovation's (CMMI) Enhancing Oncology Model (EOM). The company achieved nearly $6M in cost savings for CMS while earning a performance-based payment and improving patient outcomes.
Building on their previous success in the Oncology Care Model (OCM), where they saw a 2.6% decrease in expenditures, AON practices now represent approximately 10% of the total EOM population. The success was driven by several key initiatives implemented in partnership with Thyme Care, including:
- Pharmacy interventions focusing on drug waste minimization and therapeutic substitutions
- 24/7 comprehensive care navigation with virtual support
- Real-time performance data analytics
- Virtual palliative care support
American Oncology Network (AON) ha riportato un notevole successo nel primo periodo di performance del programma Enhancing Oncology Model (EOM) dei Centers for Medicare & Medicaid Innovation (CMMI). L'azienda ha ottenuto quasi 6 milioni di dollari di risparmi sui costi per CMS, guadagnando al contempo un pagamento basato sulle performance e migliorando i risultati per i pazienti.
Basandosi sul successo precedente nel modello Oncology Care Model (OCM), dove hanno registrato una riduzione delle spese del 2,6%, le pratiche di AON rappresentano ora circa il 10% della popolazione totale dell'EOM. Il successo è stato determinato da diverse iniziative chiave implementate in collaborazione con Thyme Care, tra cui:
- Interventi farmaceutici mirati alla riduzione degli sprechi di farmaci e alle sostituzioni terapeutiche
- Assistenza completa 24/7 con supporto virtuale
- Analisi dei dati di performance in tempo reale
- Supporto virtuale per le cure palliative
American Oncology Network (AON) ha reportado un éxito significativo en el primer periodo de desempeño del modelo Enhancing Oncology Model (EOM) de los Centers for Medicare & Medicaid Innovation (CMMI). La compañía logró casi 6 millones de dólares en ahorros de costos para CMS, mientras obtenía un pago basado en el desempeño y mejoraba los resultados de los pacientes.
Basándose en su éxito previo en el Oncology Care Model (OCM), donde experimentaron una disminución del 2.6% en gastos, las prácticas de AON ahora representan aproximadamente el 10% de la población total del EOM. El éxito fue impulsado por varias iniciativas clave implementadas en colaboración con Thyme Care, que incluyen:
- Intervenciones farmacéuticas enfocadas en minimizar el desperdicio de medicamentos y sustituciones terapéuticas
- Navegación integral de atención 24/7 con soporte virtual
- Análisis de datos de desempeño en tiempo real
- Soporte virtual para cuidados paliativos
American Oncology Network (AON)은 Centers for Medicare & Medicaid Innovation(CMMI)의 Enhancing Oncology Model(EOM) 첫 성과 기간에서 큰 성공을 보고했습니다. 회사는 CMS를 위해 거의 600만 달러의 비용 절감을 달성했으며, 성과 기반 보상을 받는 동시에 환자 결과를 개선했습니다.
이전 Oncology Care Model(OCM)에서 2.6% 지출 감소를 기록한 성공을 바탕으로, AON의 진료 기관은 현재 전체 EOM 인구의 약 10%를 차지하고 있습니다. 이러한 성공은 Thyme Care와 협력하여 실행한 여러 주요 이니셔티브에 의해 이루어졌으며, 주요 내용은 다음과 같습니다:
- 약물 낭비 최소화 및 치료 대체에 중점을 둔 약국 개입
- 24시간 연중무휴 가상 지원을 포함한 종합 진료 내비게이션
- 실시간 성과 데이터 분석
- 가상 완화 치료 지원
American Oncology Network (AON) a rapporté un succès significatif lors de la première période de performance du modèle Enhancing Oncology Model (EOM) des Centers for Medicare & Medicaid Innovation (CMMI). L'entreprise a réalisé près de 6 millions de dollars d'économies pour CMS tout en obtenant un paiement basé sur la performance et en améliorant les résultats pour les patients.
Fort de leur succès précédent dans le modèle Oncology Care Model (OCM), où ils ont observé une diminution des dépenses de 2,6 %, les pratiques AON représentent désormais environ 10 % de la population totale de l'EOM. Ce succès a été rendu possible grâce à plusieurs initiatives clés mises en œuvre en partenariat avec Thyme Care, notamment :
- Interventions pharmaceutiques visant à minimiser le gaspillage de médicaments et les substitutions thérapeutiques
- Navigation de soins complète 24h/24 et 7j/7 avec soutien virtuel
- Analyse des données de performance en temps réel
- Soutien virtuel en soins palliatifs
American Oncology Network (AON) hat im ersten Leistungszeitraum des Enhancing Oncology Model (EOM) der Centers for Medicare & Medicaid Innovation (CMMI) bedeutende Erfolge erzielt. Das Unternehmen erreichte fast 6 Millionen US-Dollar an Kosteneinsparungen für CMS, während es eine leistungsbasierte Vergütung erhielt und die Patientenergebnisse verbesserte.
Aufbauend auf dem bisherigen Erfolg im Oncology Care Model (OCM), bei dem eine Ausgabenreduzierung von 2,6 % erzielt wurde, repräsentieren AON-Praxen nun etwa 10 % der gesamten EOM-Population. Der Erfolg wurde durch mehrere wichtige Initiativen erzielt, die in Zusammenarbeit mit Thyme Care umgesetzt wurden, darunter:
- Pharmazeutische Interventionen zur Minimierung von Arzneimittelabfällen und therapeutischen Substitutionen
- Umfassende 24/7-Pflegenavigation mit virtueller Unterstützung
- Echtzeit-Analyse der Leistungsdaten
- Virtuelle palliative Versorgung
- Achieved $6M in cost savings for CMS
- Earned performance-based payment
- Represents 10% of total EOM population
- 2.6% decrease in expenditures compared to other OCM participants
- Successfully implemented cost-effective pharmacy interventions for drugs exceeding $100,000 annually
- None.
Strategic Thyme Care partnership strengthens AON’s leadership in value-based care innovation while improving patient experience and reducing costs
FORT MYERS, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced strong results from the first performance period in the Centers for Medicare & Medicaid Innovation’s (CMMI) Enhancing Oncology Model (EOM). AON practices participating in the program—in collaboration with value-based cancer care enabler Thyme Care—achieved nearly
“Our first performance period in the EOM yielded a positive outcome, validating our approach to value-based cancer care and demonstrating the strength of our leadership team, clinic staff, and partnership with Thyme Care,” said AON Chief Medical Officer Dr. Stephen “Fred” Divers. “This achievement reinforces AON’s leadership in alternative payment models, and we’re excited to implement new strategies to further enhance our performance in future performance periods.”
The results build on AON’s proven track record in value-based care, following its success in the Oncology Care Model (OCM), the predecessor to EOM, where AON practices saw significant improvements in patient outcomes and a
Key drivers of success in the EOM program:
- Pharmacy interventions: Many cancer drugs have list prices exceeding
$100,000 annually. AON’s oncologists and pharmacists lead the development and implementation of data-informed, patient-centric pharmacy interventions, in partnership with Thyme Care. These included drug waste minimization and therapeutic substitutions that reduced costs while maintaining clinical efficacy and improving adherence. - Comprehensive care navigation: AON oncologists and clinic staff, supported by Thyme Care’s 24/7 virtual care navigation team—comprised of oncology nurses, social workers, and healthcare navigators–provided comprehensive care both in the clinic and between appointments. This proactive, wraparound approach identified patients’ clinical, emotional, logistical, and health equity needs, improving the overall care experience and outcomes. Every patient interaction was documented and shared among providers and care teams, ensuring they had the right information at the right time to make informed decisions.
- Real-time performance data: AON and Thyme Care used real-time analytics from electronic health records (EHR), electronic patient-reported outcomes (ePROs), admission-discharge-transfer (ADT) feeds, and claims data to quickly identify and address issues. By continuously reviewing performance data and refining care delivery, the team reduced avoidable emergency department visits and gained deeper insights into their performance in the EOM.
- Virtual palliative care support: AON and Thyme Care provided virtual palliative care to help patients and caregivers manage physical and psychological symptoms, offering an additional layer of support throughout the cancer journey. This approach ensured patients received compassionate, patient-centered care aligned with their goals and values.
"We are incredibly proud of our achievements in the first performance period of this program," said Dr. Bobby Green, co-founder, chief medical officer, and president of Thyme Care. "We built the right systems, processes, and infrastructure from the ground up to support patients with 24/7 care, address their social needs, and use data to drive improvements. Collaborating with the AON team and combining their clinical expertise with Thyme Care’s technology and services enabled us to succeed in the EOM and deliver meaningful impact to patients. As we move forward together, we’re confident we’ll continue to improve both quality and costs."
About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
AON Contact
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com
About Thyme Care
Thyme Care is the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology-enabled Care Team and seamless integration with more than 800 oncologists in Thyme Care Oncology Partners, creating a hybrid collaborative care model that guides and supports the entire patient journey. Thyme Care empowers oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. Thyme Care is a founding member of CancerX, and is backed by leading investors. To learn more about how Thyme Care is enabling the shift to value-based care in oncology, visit www.thymecare.com.
Thyme Care Contact
Kimberly Dreisinger
Thyme Care Communications
press@thymecare.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cc9dc7e4-1a16-4289-a3c8-c6ad61f24329
FAQ
How much did American Oncology Network (AONC) save in the first EOM performance period?
What percentage of EOM population does AONC represent?
How did AONC perform in the previous Oncology Care Model (OCM)?
What key initiatives drove AONC's success in the EOM program?
How does AONC manage high-cost cancer drugs in the EOM program?
